Genexine Market Cap

Genexine has a market cap or net worth of 205.80 billion as of May 13, 2025. Its market cap has decreased by -36.10% in one year.

Market Cap

205.80B

Enterprise Value

221.96B

Revenue

5.81B

Ranking

n/a

PE Ratio

n/a

Stock Price

4,525.00

Market Cap Chart

Since September 15, 2009, Genexine's market cap has increased from 109.02B to 205.80B, an increase of 88.77%. That is a compound annual growth rate of 4.14%.

Market Cap History

Date	Market Cap	% Change
May 12, 2025	202.61B	-16.57%
Dec 30, 2024	242.86B	-40.82%
Dec 28, 2023	410.35B	-12.73%
Dec 29, 2022	470.21B	-67.78%
Dec 30, 2021	1,459.20B	-52.47%
Dec 30, 2020	3,069.93B	106.72%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	74.02T
Celltrion	33.69T
ALTEOGEN	18.39T
Yuhan	8,026.78B
HLB Co., Ltd.	7,581.42B
SK Biopharmaceuticals	7,079.52B
PharmaResearch	4,171.44B
Peptron	3,872.02B

Market Cap Rankings